Insights from the Edge of Discovery

In the world of rare disease research, information is the most valuable currency. But for too long, that information has been trapped in silos—hidden in hospital servers or buried in complex regulatory guidelines.

Welcome to the Regal Intel Journal. Here, we explore the intersection of Sovereign AI, regulatory science, and patient advocacy. From deep dives into FDA guidance changes to the latest breakthroughs in federated learning, this is your source for the intelligence that is reshaping how orphan drugs are developed. We don't just report on the future of rare disease research; we are building it.